Categories: department of state, Export, FDA Issues, Import, International Trade, Trade Policy, U.S.Customs
Search
Categories
- 10+2 (3)
- ACE (1)
- AD/CVD (18)
- Alcohol (1)
- Apparel (5)
- AT (1)
- Best Practices (146)
- Bioterrorism Act (5)
- BIS (3)
- Brazil (2)
- Brokers (1)
- C-TPAT (20)
- Canada (1)
- Caribbean Basin Initiative (2)
- CBD (3)
- CBERA (2)
- CBI (2)
- CBP (197)
- CBP 28 (5)
- CBP 29 (5)
- CBTPA (2)
- CEE (3)
- China (55)
- China Trade War (57)
- comments (1)
- compliance (72)
- Counterfeit (17)
- COVID-19 (8)
- CPSC (4)
- Cuba (21)
- Customs Bond (4)
- Customs Expert (110)
- DDTC (1)
- Department of Homeland Security (36)
- department of state (14)
- detention (15)
- DHS (4)
- dietary supplement (2)
- DOC (8)
- DOJ (1)
- DOL (1)
- E-Cigarettes (3)
- EAR (2)
- ECCN (1)
- EEI (1)
- Election 2020 (3)
- Enforcement (72)
- EPA (6)
- Events (54)
- Expert (50)
- Export (162)
- FAA (1)
- FBI (1)
- FCPA (2)
- FDA (51)
- FDA Issues (111)
- Cosmetics (2)
- E-Cigarette (2)
- Food (50)
- FSMA (28)
- Gluten Free (3)
- Import Alert (26)
- Medical Devices (7)
- Tobacco (4)
- FDA Notice of Detention (7)
- Final Rule (7)
- FMC (4)
- Forced Labor (4)
- Form 766 (1)
- Free Trade Agreement (10)
- Freight Forwarding (6)
- FTA (2)
- FTC (1)
- GATS (1)
- GDP (1)
- Global Entry (2)
- GOLDMAN (1)
- Government shutdown (1)
- GSP (2)
- HTS (5)
- HTSUS (21)
- Import (225)
- Customs Broker (39)
- Import Alert (19)
- intellectual property rights (46)
- International Business (82)
- International Law (141)
- International Trade (173)
- International Travel (46)
- Investigation (19)
- IPR, Trademarks and Logos (42)
- Counterfeits (20)
- IRAN (3)
- ISA (2)
- ISF (2)
- ITAR (2)
- ITC (2)
- Jobs (2)
- Labeling (10)
- labor rights (1)
- Lacey Act (1)
- license (9)
- Liquidated damages (6)
- List 4A (1)
- LVC (1)
- Medical Device (7)
- Mexico (1)
- Mitigation (4)
- MSRP (1)
- MTB (1)
- NAFTA (6)
- Notice of Refusal (2)
- OFAC (2)
- offline (1)
- OMB (1)
- OTC Drug (3)
- OWIT (10)
- OWIT-South Florida (6)
- penalty (10)
- petition (4)
- PGA (1)
- PHIB (1)
- PPE (1)
- pre-compliance (29)
- PREDICT (1)
- Professional Speaker (14)
- proposed rule (5)
- Protest (2)
- Reasonable Care (7)
- SEC (1)
- Seizure (33)
- Speaker (8)
- Speaking (25)
- special 301 (2)
- Supply Chain (40)
- Symposium (4)
- Technology (7)
- TPP (1)
- trade (63)
- Trade Policy (1)
- Trade Transformation (4)
- Trade War (44)
- Trademark Recordation (7)
- Trusted Trader (3)
- TSA (16)
- U.S. Fish and Wildlife Service (2)
- U.S.Customs (114)
- Currency Seizure (9)
- Uncategorized (45)
- USDA (1)
- USITC (1)
- USMCA (3)
- USSF (1)
- USTR (4)
- Vehicles (3)
- Vietnam (1)
Archive
- March 2021 (1)
- February 2021 (6)
- January 2021 (9)
- December 2020 (13)
- November 2020 (6)
- October 2020 (9)
- September 2020 (6)
- August 2020 (4)
- July 2020 (4)
- June 2020 (4)
- May 2020 (4)
- April 2020 (4)
- March 2020 (2)
- January 2020 (4)
- December 2019 (3)
- November 2019 (2)
- October 2019 (5)
- September 2019 (3)
- August 2019 (5)
- July 2019 (3)
- June 2019 (6)
- May 2019 (4)
- April 2019 (3)
- March 2019 (5)
- February 2019 (2)
- January 2019 (4)
- December 2018 (3)
- November 2018 (3)
- October 2018 (1)
- September 2018 (1)
- August 2018 (6)
- July 2018 (7)
- June 2018 (5)
- May 2018 (6)
- April 2018 (5)
- March 2018 (2)
- February 2018 (3)
- January 2018 (7)
- December 2017 (2)
- November 2017 (2)
- October 2017 (4)
- September 2017 (2)
- August 2017 (3)
- July 2017 (1)
- June 2017 (4)
- May 2017 (3)
- April 2017 (8)
- March 2017 (3)
- February 2017 (4)
- January 2017 (6)
- December 2016 (4)
- November 2016 (3)
- October 2016 (1)
- September 2016 (4)
- August 2016 (1)
- July 2016 (4)
- June 2016 (1)
- May 2016 (2)
- April 2016 (2)
- March 2016 (1)
- February 2016 (4)
- January 2016 (2)
- December 2015 (2)
- November 2015 (2)
- October 2015 (3)
- September 2015 (1)
- August 2015 (1)
- July 2015 (3)
- June 2015 (3)
- May 2015 (4)
- April 2015 (4)
- March 2015 (1)
- January 2015 (2)
- December 2014 (4)
- October 2014 (6)
- September 2014 (1)
- August 2014 (2)
- July 2014 (4)
- June 2014 (2)
- May 2014 (5)
- April 2014 (3)
- March 2014 (1)
- December 2013 (2)
- November 2013 (3)
- October 2013 (3)
- September 2013 (4)
- August 2013 (1)
- July 2013 (7)
- June 2013 (2)
- May 2013 (5)
- April 2013 (5)
- March 2013 (9)
- February 2013 (5)
- January 2013 (4)
- December 2012 (4)
- November 2012 (3)
- October 2012 (7)
- September 2012 (5)
- August 2012 (6)
- July 2012 (4)
- June 2012 (1)
- May 2012 (3)
- March 2012 (4)
- February 2012 (8)
- January 2012 (5)
- December 2011 (5)
- November 2011 (1)
- October 2011 (4)
- August 2011 (6)
- July 2011 (2)
- April 2011 (4)
- March 2011 (3)
- February 2011 (3)
- January 2011 (3)
- December 2010 (2)
- November 2010 (4)
- October 2010 (2)
- September 2010 (3)
- August 2010 (7)
- July 2010 (1)
- June 2010 (2)
- May 2010 (5)
- April 2010 (4)
- March 2010 (4)
- February 2010 (6)
- January 2010 (7)
- December 2009 (2)
- November 2009 (7)
- October 2009 (9)
- September 2009 (4)
- August 2009 (9)
- May 2008 (1)
- July 2007 (1)
Biden Administration Commits to Modernizing Regulatory Review
By Jennifer Diaz | February 9, 2021
Co-Authored by Sharath Patil
Background on Regulatory Review
U.S. federal laws come from a wide array of sources. They are generally organized under the following order of authority: 1) the U.S. constitution, 2) statutes passed by Congress, 3) treaties ratified by Congress, 4) case law, 5) executive orders, 6) regulations, and 7) agency guidance. After Congress has provided a federal agency with a policy mandate, an agency is empowered to promulgate regulations to provide detailed and binding rules on those matters.
Executive Order 12866 (signed by President Bill Clinton on September 30, 1993), as amended, directs agencies to follow certain principles in rulemaking, such as consideration of alternatives and engage in a cost-benefit analysis. Significant proposed regulations are reviewed by the White House’s Office of Information and Regulatory Affairs (“OIRA”) and the Office of Management and Budget (“OMB”).
Biden Issues Guidance on Modernizing Regulatory Review
In the first days of his administration, President Biden issued two memoranda committing to modernize regulatory review and signed an executive order revoking Trump-era executive orders on rulemaking. These two memoranda and executive order are explained below, in turn.
Memo #1: Modernizing Regulatory Review
In the memorandum addressed to the heads of executive departments and agencies on January 20, 2021, President Biden underscored the need for a regulatory review mechanism that permits “swift and effective Federal action” amidst serious challenges including “a massive global pandemic; a major economic downturn; systemic racial inequality; and the undeniable reality and accelerating threat of climate change.”
The memorandum directed the Director of OMB to begin a process of producing a set of recommendations for improving and modernizing regulatory review. The memo required these recommendations to provide concrete suggestions on how the regulatory review process can promote: public health and safety, economic growth, social welfare, racial justice, environmental stewardship, human dignity, equity, and the interests of future generations.
In particular, the memo required OMB’s recommendations to:
Memo #2: Regulatory Freeze Pending Review
Biden’s Chief of Staff, Ron Klein, released a second memorandum on the same day freezing regulatory rulemaking pending review. The memo requires:
Executive Order Revoking Trump-Era Rulemaking Executive Orders
Additionally, President Biden signed Executive Order 13992 on the Revocation of Certain Executive Orders Concerning Federal Regulation on January 20, 2021. The Executive Order revoked a set of Trump-era policies and directives that the Biden administration found to restrain the government from proactively addressing national priorities.
Specifically, EO 13992 revoked:
Furthermore, EO 13992 directed the OMB Director and heads of agencies to rescind any orders, rules, regulations, guidelines, or policies the implemented or enforced the revoked executive orders.
Trade & Customs Implications
Rulemaking has important implications for trade and customs matters. A wide array of federal agencies including the U.S. Department of Commerce, U.S. Customs and Border Protection, the U.S. Department of State, the U.S. Department of the Treasury, the U.S. Food and Drug Administration and many others routinely promulgate regulations that affect various aspects of U.S. trade and customs law.
Diaz Trade Law’s Upcoming Webinar: Forecasting the Next 4 Years of Biden on Trade
On March 3, 2021 at 12:00 PM, Diaz Trade Law is hosting a webinar on Forecasting the Next 4 Years of Biden on Trade. The webinar will provide a retrospective overview of U.S.-China trade relations under Trump, explain where we are now, and forecast U.S.-China relations under Biden. Specifically, the presenters will discuss how exporters and particular industries will be affected and forecast the impact of a Biden administration on U.S. Customs and Border Protection trade issues. Our featured speaker, Todd Owen, Former Executive Assistant Commissioner for the Office of Field Operations at U.S. Customs and Border Protection, will be our featured speaker. Todd will be joined by Diaz Trade Law’s president, Jennifer Diaz, and Associate Attorney Sharath Patil.
Contact Us
If you have questions on how Biden’s regulatory agenda may affect your business, require assistance drafting comments on upcoming rulemaking, or have general questions on trade and customs matters, contact us today at info@diaztradelaw.com or 305-456-3830.